...don't even ignore 'em.
-- Samuel Goldwyn

Monday, December 18, 2006


The FDA is looking into Eli Lilly's promotion of Zyprexa for other conditions besides those for which it's approved: schizophrenia and bipolar disorder. Read about it here in the NYT, and notice especially the words of the Lilly sales executive. It's good, I guess, that FDA looks into problems like this. But who's looking into the physicians who actually prescribed the drug "off-label" after a Lilly rep's pitch? Who regulates fools who rely on drug reps to tell them how to treat their patients?

1 comment:

Daniel Haszard said...

Eli Lilly Zyprexa scandal

Zyprexa off label promotion scandal is all over the news now.
Lilly drug reps are alleged to have called their marketing ploy,"Viva zyprexa".

Eli Lilly zyprexa cost me over $250.00 a month supply out of my own pocket X 4 years and has up to ten times the risk (over non users) of causing diabetes and severe weight gain.

Zyprexa which is only FDA approved for schizophrenia (.5-1% of pop) and some bipolar (2% pop) and then an even smaller percentage of theses two groups.
So how does Zyprexa get to be the 7th largest drug sale in the world?
Eli Lilly is in deep trouble for using their drug reps to 'encourage' doctors to write zyprexa for non-FDA approved 'off label' uses.

The drug causes increased diabetes risk,and medicare picks up all the expensive fallout.There are now 7 states (and counting) going after Lilly for fraud and restitution.

Only 9 percent of adult Americans think the pharmaceutical industry can be trusted right around the same rating as big tobacco.

Daniel Haszard zyprexa-victims.com